ATHE
ALTERI THERA SP ADS (ATHE)
NASDAQ
$4.05+$0.03 (+0.62%)
Price as of Jun 03, 2026 4:10 PM EDT
  • $74.7M
    Market Cap
  • -12.24%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
06/30/2023
06/30/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-14.4M
-22.74%
-18.6M
+41.26%
-13.2M
-10.49%
-14.7M
+20.04%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
5.5M
+15.09%
4.8M
-5.81%
5.1M
-8.29%
5.5M
-20.52%
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-6,188
-14.26%
-7,217
+58.09%
-4,565
+99.78%
-2,285
+75.90%
Interest Income and Expense and Net
-6,188
-14.26%
-7,217
+58.09%
-4,565
+99.78%
-2,285
+75.90%
Total Nonoperating Income and Expense
7.6M
+90.12%
4.0M
+2.63%
3.9M
-23.56%
5.1M
+14.23%
Income before Taxes
-12.1M
-36.48%
-19.1M
+38.51%
-13.8M
+7.47%
-12.8M
-16.08%
Income Taxes
68,055
+47.66%
46,088
-55.88%
104,459
+49.21%
70,008
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-12.1M
-36.48%
-19.1M
+38.51%
-13.8M
+7.47%
-12.8M
-16.08%
Net Income from Continuing Operations Applicable to Common
-12.1M
-36.48%
-19.1M
+38.51%
-13.8M
+7.47%
-12.8M
-16.08%
Basic EPS and Net Income
-0.19
-63.46%
-0.52
-8.77%
-0.57
+7.55%
-0.53
N/A
Diluted EPS and Net Income
-0.19
-63.46%
-0.52
-8.77%
-0.57
+7.55%
-0.53
-41.11%
Basic Weighted Average Shares
6.4B
+75.31%
3.6B
+50.29%
2.4B
+0.91%
2.4B
N/A
Diluted Weighted Average Shares
6.4B
+75.31%
3.6B
+50.29%
2.4B
+0.91%
2.4B
N/A
Balance Sheet
Cash and Cash Equivalents
33.2M
+162.35%
12.6M
-19.87%
15.8M
-54.68%
34.8M
+23.80%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
33.2M
+162.35%
12.6M
-19.87%
15.8M
-54.68%
34.8M
+23.80%
Total Current Assets
45.9M
+140.96%
19.0M
-29.62%
27.0M
-34.26%
41.1M
+22.86%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
3,848
-88.03%
32,154
-47.95%
61,776
-39.76%
102,551
+227.50%
Total Long-Term Assets
155,174
-16.97%
186,883
-30.49%
268,863
+23.04%
218,522
+125.73%
Total Assets
46.0M
+139.42%
19.2M
-29.63%
27.3M
-33.96%
41.4M
+23.16%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
3.5M
-34.22%
5.4M
+22.63%
4.4M
-24.71%
5.8M
+89.74%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
88,545
+70.56%
51,914
-57.69%
122,710
+66.70%
73,610
+54.41%
Total Liabilities
3.6M
-33.22%
5.4M
+20.44%
4.5M
-23.57%
5.9M
+89.20%
Retained Earnings
-225.9M
-205.48%
214.2M
+209.75%
-195.1M
+7.28%
-181.9M
+7.16%
Total Stockholders Equity
42.4M
+207.31%
13.8M
-39.52%
22.8M
-35.68%
35.5M
+16.40%
Total Shares Outstanding
9.1B
+73.58%
5.3B
+115.52%
2.4B
+1.37%
2.4B
+15.49%
Cash Flow
Cash from Operating Activities
-11.5M
-9.16%
-12.6M
-37.08%
-20.0M
+62.40%
-12.3M
-28.81%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-7.5M
+130,973.05%
-5,722
-84.31%
-36,461
-59.10%
-89,147
+751.29%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
39.7M
+330.43%
9.2M
+7,312.17%
124,340
-99.24%
16.3M
-55.56%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-37.23%
-54.69%
-82.18%
+104.40%
-40.21%
+17.28%
-34.28%
-51.30%
Return on Equity
-43.23%
-58.62%
-104.47%
+120.50%
-47.38%
+21.59%
-38.97%
-52.12%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
12.98
+266.32%
3.54
-42.61%
6.17
-12.68%
7.07
-35.25%
Cash Ratio
9.38
+298.84%
2.35
-34.66%
3.60
-39.81%
5.98
-34.75%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow